Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

No neurodevelopmental benefit of cerebral oximetry in the first randomised trial in preterm infants during the first days of life (SafeBoosC II)

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Plomgaard, AM, Alderliesten, T, van Bel, F, Benders, M, Claris, O, Cordeiro, M, Dempsey, E, Fumagalli, M, Gluud, C, Hyttel-Sorensen, S, Lemmers, P, Pellicer, A, Pichler, G & Greisen, G 2019, 'No neurodevelopmental benefit of cerebral oximetry in the first randomised trial in preterm infants during the first days of life (SafeBoosC II)' Acta paediatrica, vol. 108, no. 2, pp. 275-281. https://doi.org/10.1111/apa.14463

APA

CBE

MLA

Vancouver

Author

Plomgaard, Anne M ; Alderliesten, Thomas ; van Bel, Frank ; Benders, Manon ; Claris, Olivier ; Cordeiro, Malaika ; Dempsey, Eugene ; Fumagalli, Monica ; Gluud, Christian ; Hyttel-Sorensen, Simon ; Lemmers, Petra ; Pellicer, Adelina ; Pichler, Gerhard ; Greisen, Gorm. / No neurodevelopmental benefit of cerebral oximetry in the first randomised trial in preterm infants during the first days of life (SafeBoosC II). In: Acta paediatrica. 2019 ; Vol. 108, No. 2. pp. 275-281.

Bibtex

@article{5873f1e014f54b1391fb6da5042fb35f,
title = "No neurodevelopmental benefit of cerebral oximetry in the first randomised trial in preterm infants during the first days of life (SafeBoosC II)",
abstract = "AIM: Cerebral hypoxia has been associated with neurodevelopmental impairment. We studied whether reducing cerebral hypoxia in extremely preterm infants during the first 72 hours of life affected neurological outcomes at two years of corrected age.METHODS: In 2012-2013 the phase II randomised Safeguarding the Brains of our Smallest Children trial compared visible cerebral near infrared spectroscopy (NIRS) monitoring in an intervention group and blinded NIRS monitoring in a control group. Cerebral hypoxia was significantly reduced in the intervention group. We followed up 115 survivors from eight European centres at two years of corrected age, by conducting a medical examination and assessing their neurodevelopment with the Bayley Scales of Infant and Toddler Development, Second or Third Edition and the parental Ages and Stages Questionnaire, (ASQ).RESULTS: There were no respective differences between the intervention (n=65) and control (n=50) groups with regard to the mean mental developmental index (89.6 ±19.5 versus 88.4 ±14.7, p=0.77), ASQ score (215 ±58 versus 213 ±58, p=0.88) and the number of children with moderate-to-severe neurodevelopmental impairment (10 versus six, p=0.58).CONCLUSIONS: Cerebral NIRS monitoring was not associated with long-term benefits or harm with regard to neurodevelopmental outcome at two years of corrected age. This article is protected by copyright. All rights reserved.",
author = "Plomgaard, {Anne M} and Thomas Alderliesten and {van Bel}, Frank and Manon Benders and Olivier Claris and Malaika Cordeiro and Eugene Dempsey and Monica Fumagalli and Christian Gluud and Simon Hyttel-Sorensen and Petra Lemmers and Adelina Pellicer and Gerhard Pichler and Gorm Greisen",
note = "This article is protected by copyright. All rights reserved.",
year = "2019",
doi = "10.1111/apa.14463",
language = "English",
volume = "108",
pages = "275--281",
journal = "Acta paediatrica",
issn = "1651-2227",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "2",

}

RIS

TY - JOUR

T1 - No neurodevelopmental benefit of cerebral oximetry in the first randomised trial in preterm infants during the first days of life (SafeBoosC II)

AU - Plomgaard, Anne M

AU - Alderliesten, Thomas

AU - van Bel, Frank

AU - Benders, Manon

AU - Claris, Olivier

AU - Cordeiro, Malaika

AU - Dempsey, Eugene

AU - Fumagalli, Monica

AU - Gluud, Christian

AU - Hyttel-Sorensen, Simon

AU - Lemmers, Petra

AU - Pellicer, Adelina

AU - Pichler, Gerhard

AU - Greisen, Gorm

N1 - This article is protected by copyright. All rights reserved.

PY - 2019

Y1 - 2019

N2 - AIM: Cerebral hypoxia has been associated with neurodevelopmental impairment. We studied whether reducing cerebral hypoxia in extremely preterm infants during the first 72 hours of life affected neurological outcomes at two years of corrected age.METHODS: In 2012-2013 the phase II randomised Safeguarding the Brains of our Smallest Children trial compared visible cerebral near infrared spectroscopy (NIRS) monitoring in an intervention group and blinded NIRS monitoring in a control group. Cerebral hypoxia was significantly reduced in the intervention group. We followed up 115 survivors from eight European centres at two years of corrected age, by conducting a medical examination and assessing their neurodevelopment with the Bayley Scales of Infant and Toddler Development, Second or Third Edition and the parental Ages and Stages Questionnaire, (ASQ).RESULTS: There were no respective differences between the intervention (n=65) and control (n=50) groups with regard to the mean mental developmental index (89.6 ±19.5 versus 88.4 ±14.7, p=0.77), ASQ score (215 ±58 versus 213 ±58, p=0.88) and the number of children with moderate-to-severe neurodevelopmental impairment (10 versus six, p=0.58).CONCLUSIONS: Cerebral NIRS monitoring was not associated with long-term benefits or harm with regard to neurodevelopmental outcome at two years of corrected age. This article is protected by copyright. All rights reserved.

AB - AIM: Cerebral hypoxia has been associated with neurodevelopmental impairment. We studied whether reducing cerebral hypoxia in extremely preterm infants during the first 72 hours of life affected neurological outcomes at two years of corrected age.METHODS: In 2012-2013 the phase II randomised Safeguarding the Brains of our Smallest Children trial compared visible cerebral near infrared spectroscopy (NIRS) monitoring in an intervention group and blinded NIRS monitoring in a control group. Cerebral hypoxia was significantly reduced in the intervention group. We followed up 115 survivors from eight European centres at two years of corrected age, by conducting a medical examination and assessing their neurodevelopment with the Bayley Scales of Infant and Toddler Development, Second or Third Edition and the parental Ages and Stages Questionnaire, (ASQ).RESULTS: There were no respective differences between the intervention (n=65) and control (n=50) groups with regard to the mean mental developmental index (89.6 ±19.5 versus 88.4 ±14.7, p=0.77), ASQ score (215 ±58 versus 213 ±58, p=0.88) and the number of children with moderate-to-severe neurodevelopmental impairment (10 versus six, p=0.58).CONCLUSIONS: Cerebral NIRS monitoring was not associated with long-term benefits or harm with regard to neurodevelopmental outcome at two years of corrected age. This article is protected by copyright. All rights reserved.

U2 - 10.1111/apa.14463

DO - 10.1111/apa.14463

M3 - Journal article

VL - 108

SP - 275

EP - 281

JO - Acta paediatrica

JF - Acta paediatrica

SN - 1651-2227

IS - 2

ER -

ID: 54639653